The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...

On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...

Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...

This is not the kind of honor I ever anticipated on my life bingo card. But I never expected a Parkinson’s disease diagnosis, either. Or starting a foundation that bears my name, which has ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF ...

Goldman, MD, MPH, who, with colleagues, published the largest study to show high levels of TCE exposure are associated with an increased risk of Parkinson’s Disease. He explains some of the science ...

Over an average follow-up period of 14.24 years, 810 participants were subsequently diagnosed with Parkinson's disease. The analysis revealed a 57% increased risk of Parkinson's for every 10 ...